Prevention of Transplant Rejection
- 1 October 1997
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 54 (4) , 533-570
- https://doi.org/10.2165/00003495-199754040-00003
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- EVIDENCE THAT LONG-TERM CARDIAC ALLOGRAFT SURVIVAL INDUCED BY ANTI-CD4 MONOCLONAL ANTIBODY DOES NOT REQUIRE DEPLETION OF CD4+ T CELLSTransplantation, 1992
- A Review of Assay Methods for CyclosporinClinical Pharmacokinetics, 1992
- WITHDRAWAL OF STEROIDS AFTER RENAL TRANSPLANTATION—CLINICAL PREDICTORS OF OUTCOME1Transplantation, 1992
- EFFECTS OF STEROID WITHDRAWAL ON POSTTRANSPLANT DIABETES MELLITUS IN CYCLOSPORINE-TREATED RENAL TRANSPLANT RECIPIENTSTransplantation, 1991
- RS-61443—A NEW, POTENT IMMUNOSUPPRESSIVE AGENTTransplantation, 1991
- CyclosporineNew England Journal of Medicine, 1989
- Muromonab CD3Drugs, 1989
- T-cell antigen receptor genes and T-cell recognitionNature, 1988
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1986
- Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.The Journal of Antibiotics, 1975